MIPS # PIMSH4 Patient Reported Pain Improvement
2026 measure specification review pending.
MEASURE DESCRIPTION
Percentage of cancer patients currently receiving chemotherapy or radiation therapy who report significant pain improvement (high to moderate, moderate to low, or high to low) within 30 days.
Relevance to Value Based Care
Pain is one of the most common symptoms associated with cancer. It is important to regularly ask patients about their pain and modify treatment accordingly, in order to reduce pain and help improve quality of life.
Numerator
Patients who report pain level improvement within 30 days (high to moderate, moderate to low, or high to low); high 7-10, moderate 4-6, low 3 and below on a 10-point scale.
Denominator
All patients, regardless of patient age, with a cancer diagnosis currently receiving chemotherapy (all oncolytics except hormone therapy) or radiation therapy who report a pain level higher than 3 on a pain scale of 0-10 during a qualifying E/M visit.
Exclusion/Exceptions
Patients who have died prior to 30-day follow up or hospice enrollment
Patient refusal of pain management intervention
Telehealth included: Yes
Scoring: Up to 10 points
RESOURCES
